CASI Pharmaceuticals, Inc. (CASIF) Financials

CASIF Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2025 24.5 million 53.1 million
June 30, 2025 31.2 million 51.5 million
March 31, 2025 40.8 million 48.9 million
Dec. 31, 2024 53.7 million 51.8 million

CASIF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2025 ? ?
June 30, 2025 ? ?
March 31, 2025 ? ?
Dec. 31, 2024 ? 1.3 million

CASIF Net Income

No data available :(

CASIF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2025 4.7 million - -
June 30, 2025 6.8 million - -
March 31, 2025 12.7 million - -
Dec. 31, 2024 16.1 million - 3.8 million

CASIF Shares Outstanding

No data available :(

CASIF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2025 - 1.4 million 9.5 million 4.6 million
June 30, 2025 - 1.7 million 11.0 million 5.0 million
March 31, 2025 - 1.9 million 11.9 million 4.2 million
Dec. 31, 2024 - 3.7 million 11.9 million 4.8 million

CASIF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2025 3.1 million 2.4 million
June 30, 2025 4.2 million 2.1 million
March 31, 2025 6.2 million 2.6 million
Dec. 31, 2024 13.4 million 10.1 million

CASIF

Price: $0.18

52 week price:
0.05
3.09

Earnings Per Share: -3.02 USD

P/E Ratio: -0.05

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 2.2 million

Links: